These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 11181943)
1. Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease. Hayakawa T; Chang MC; Rapoport SI; Appel NM J Pharmacol Exp Ther; 2001 Mar; 296(3):1074-84. PubMed ID: 11181943 [TBL] [Abstract][Full Text] [Related]
2. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Bhattacharjee AK; Chang L; Lee HJ; Bazinet RP; Seemann R; Rapoport SI Psychopharmacology (Berl); 2005 Aug; 180(4):735-42. PubMed ID: 16163535 [TBL] [Abstract][Full Text] [Related]
3. Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats. Guo M; Xiang T; Li M; Sun Y; Sun S; Chen D; Jia Q; Li Y; Yao X; Wang X; Zhang X; He F; Wang M Behav Brain Res; 2021 Aug; 411():113339. PubMed ID: 33945831 [TBL] [Abstract][Full Text] [Related]
4. Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Yoshimura N; Kuno S; Chancellor MB; De Groat WC; Seki S Br J Pharmacol; 2003 Aug; 139(8):1425-32. PubMed ID: 12922929 [TBL] [Abstract][Full Text] [Related]
5. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons. Ruskin DN; Bergstrom DA; Walters JR J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570 [TBL] [Abstract][Full Text] [Related]
6. Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease. Hayakawa T; Chang MC; Bell JM; Seeman R; Rapoport SI; Appel NM Brain Res; 1998 Oct; 807(1-2):177-81. PubMed ID: 9757030 [TBL] [Abstract][Full Text] [Related]
7. Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Basselin M; Chang L; Bell JM; Rapoport SI Neuropsychopharmacology; 2005 Jun; 30(6):1064-75. PubMed ID: 15812572 [TBL] [Abstract][Full Text] [Related]
8. Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain. Bhattacharjee AK; Chang L; Chen M; White L; Bell JM; Bazinet RP; Rapoport SI Int J Neuropsychopharmacol; 2008 Nov; 11(7):957-69. PubMed ID: 18570702 [TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease. Bhattacharjee AK; Meister LM; Chang L; Bazinet RP; White L; Rapoport SI Neuroimage; 2007 Oct; 37(4):1112-21. PubMed ID: 17681816 [TBL] [Abstract][Full Text] [Related]
11. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat. Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422 [TBL] [Abstract][Full Text] [Related]
12. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
13. Effects of the intrastriatal administration of selective dopaminergic agonists on Fos expression in the rat brain. Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G Neurol Sci; 2002 Sep; 23 Suppl 2():S57-8. PubMed ID: 12548342 [TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
15. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ; Marshall JF Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762 [TBL] [Abstract][Full Text] [Related]
16. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease. Lindgren HS; Ohlin KE; Cenci MA Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087 [TBL] [Abstract][Full Text] [Related]
17. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism. Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163 [TBL] [Abstract][Full Text] [Related]
19. Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats. Bhattacharjee AK; Chang L; White L; Bazinet RP; Rapoport SI Psychopharmacology (Berl); 2008 May; 197(4):557-66. PubMed ID: 18274730 [TBL] [Abstract][Full Text] [Related]
20. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex. Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]